Biomerica, Inc. (BMRA)
Pre-Market:
| Previous Close | 3.9200 |
| Open | 3.8700 |
| Bid | 3.5900 x 800 |
| Ask | 4.0600 x 900 |
| Day's Range | 3.8000 - 4.1000 |
| 52 Week Range | 2.5600 - 7.3800 |
| Volume | |
| Avg. Volume | 317,963 |
| Market Cap | 49.791M |
| Beta (5Y Monthly) | -0.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4700 |
| Earnings Date | Oct 12, 2022 - Oct 17, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
Aware® is a simple at-home device to increase sensitivity in breast self-exams. About 80% of breast cancer is detected by women themselves who notice changes in their breast.EZ Detect™ is a simple 2-minute, at-home test which detects an early warning sign of colorectal cancer IRVINE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Company’s Aware® Breast Self Exam device and EZ Detect Colon Disease test are now being sold on Amaz
- Simply Wall St.
We're Interested To See How Biomerica (NASDAQ:BMRA) Uses Its Cash Hoard To Grow
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- GlobeNewswire
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
InFoods® IBS commercial launch and revenues expected before the close of calendar year 2022Mr. Carlson is an accomplished and performance-driven Commercial and Corporate Strategy and Development Executive IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced plans to launch its InFoods® IBS test before calendar year end. The test will be performed in a CLIA-certified, high-complexity laboratory facility and offered as a laboratory develo
